95 related articles for article (PubMed ID: 10530769)
41. Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.
Smith TJ; Stoner GD; Yang CS
Cancer Res; 1995 Dec; 55(23):5566-73. PubMed ID: 7585636
[TBL] [Abstract][Full Text] [Related]
42. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats.
Guo Z; Smith TJ; Thomas PE; Yang CS
Arch Biochem Biophys; 1992 Oct; 298(1):279-86. PubMed ID: 1524438
[TBL] [Abstract][Full Text] [Related]
43. Distribution of glucocorticoid and mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenases in human and rat ocular tissues.
Stokes J; Noble J; Brett L; Phillips C; Seckl JR; O'Brien C; Andrew R
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1629-38. PubMed ID: 10845579
[TBL] [Abstract][Full Text] [Related]
44. 11beta-Hydroxysteroid dehydrogenase type 1: tissue-specific expression and reductive metabolism of some anti-insect agent azole analogues of metyrapone.
Bannenberg G; Martin HJ; Bélai I; Maser E
Chem Biol Interact; 2003 Feb; 143-144():449-57. PubMed ID: 12604231
[TBL] [Abstract][Full Text] [Related]
45. Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism.
Hult M; Elleby B; Shafqat N; Svensson S; Rane A; Jörnvall H; Abrahmsen L; Oppermann U
Cell Mol Life Sci; 2004 Apr; 61(7-8):992-9. PubMed ID: 15095019
[TBL] [Abstract][Full Text] [Related]
46. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
[TBL] [Abstract][Full Text] [Related]
47. Chemopreventive efficacy of suberoylanilide hydroxamic acid (SAHA) against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice.
Desai D; Das A; Cohen L; el-Bayoumy K; Amin S
Anticancer Res; 2003; 23(1A):499-503. PubMed ID: 12680257
[TBL] [Abstract][Full Text] [Related]
48. 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase.
Maser E; Völker B; Friebertshäuser J
Biochemistry; 2002 Feb; 41(7):2459-65. PubMed ID: 11841241
[TBL] [Abstract][Full Text] [Related]
49. The Role of Placental Carbonyl Reducing Enzymes in Biotransformation of Bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone.
Fokina VM; Patrikeeva SL; Oncken C; Hankins GDV; Ahmed MS; Nanovskaya T
Drug Metab Lett; 2017 Nov; 11(1):29-34. PubMed ID: 28595558
[TBL] [Abstract][Full Text] [Related]
50. Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes.
Bader T; Zoumakis E; Friedberg M; Hiroi N; Chrousos GP; Hochberg Z
Horm Metab Res; 2002; 34(11-12):752-7. PubMed ID: 12660894
[TBL] [Abstract][Full Text] [Related]
51. In vivo characterization of 11beta-hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint.
Ajilore OA; Sapolsky RM
Neuroendocrinology; 1999 Feb; 69(2):138-44. PubMed ID: 9986927
[TBL] [Abstract][Full Text] [Related]
52. Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes.
Jorquera R; Castonguay A; Schuller HM
Drug Metab Dispos; 1992; 20(4):510-7. PubMed ID: 1356727
[TBL] [Abstract][Full Text] [Related]
53. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1.
Jamieson PM; Nyirenda MJ; Walker BR; Chapman KE; Seckl JR
J Endocrinol; 1999 Jan; 160(1):103-9. PubMed ID: 9854182
[TBL] [Abstract][Full Text] [Related]
54. Intracrine induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by glucocorticoid potentiates prostaglandin production in the human chorionic trophoblast.
Sun K; He P; Yang K
Biol Reprod; 2002 Nov; 67(5):1450-5. PubMed ID: 12390875
[TBL] [Abstract][Full Text] [Related]
55. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
[TBL] [Abstract][Full Text] [Related]
56. The novel anticancer drug oracin: different stereospecificity and cooperativity for carbonyl reduction by purified human liver 11beta-hydroxysteroid dehydrogenase type 1.
Wsól V; Szotáková B; Skálová L; Maser E
Toxicology; 2004 May; 197(3):253-61. PubMed ID: 15033547
[TBL] [Abstract][Full Text] [Related]
57. Full induction of rat myometrial 11beta-hydroxysteroid dehydrogenase type 1 in late pregnancy is dependent on intrauterine occupancy.
Waddell BJ; Burton PJ
Biol Reprod; 2000 Apr; 62(4):1005-9. PubMed ID: 10727270
[TBL] [Abstract][Full Text] [Related]
58. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates.
Smith TJ; Guo ZY; Thomas PE; Chung FL; Morse MA; Elkind K; Yang CS
Cancer Res; 1990 Nov; 50(21):6817-22. PubMed ID: 2208146
[TBL] [Abstract][Full Text] [Related]
59. Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction.
Diederich S; Hanke B; Oelkers W; Bähr V
J Clin Endocrinol Metab; 1997 May; 82(5):1598-602. PubMed ID: 9141556
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate.
Smith TJ; Guo Z; Li C; Ning SM; Thomas PE; Yang CS
Cancer Res; 1993 Jul; 53(14):3276-82. PubMed ID: 8324738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
